Key result
Transcatheter pulmonary valve implantation using the Edwards SAPIEN valve in the native RVOT was successful, resulting in a peak systolic gradient of 22 mmHg and no pulmonary regurgitation at 6 months.
Why the study?
Although transcatheter pulmonary valve implantation is established, challenging cases still require personalized solutions.
Is transcatheter pulmonary valve implantation using an Edwards SAPIEN valve feasible in the native RVOT of a patient with repaired tetralogy of Fallot?
Case Report (n=1)
No
Is transcatheter pulmonary valve implantation using an Edwards SAPIEN valve feasible in the native RVOT of a patient with repaired tetralogy of Fallot?
Transcatheter pulmonary valve replacement using an Edwards SAPIEN valve in a native RVOT is a feasible alternative to surgery for patients with repaired tetralogy of Fallot and progressive pulmonary regurgitation.
Answers are grounded in this paper and cite their sources.
Supports feasibility of TPVI in native RVOT for selected congenital cases; leaves open durability and broader applicability.
Transcatheter pulmonary valve implantation has been a well-known method for more than a decade, but there are still many challenging cases when a personalized solution is needed. We report a case of a 15-year-old female patient with tetralogy of Fallot, who underwent a surgical correction during infancy. Because of progressive pulmonary regurgitation, stenosis, and right ventricle dilatation, transcatheter pulmonary valve implantation in the native right ventricle outflow tract (RVOT) using Edwards SAPIEN valve was performed. A "landing zone" was created prior to the intervention of stenting the RVOT and the right pulmonary artery. The transcatheter approach for pulmonary valve replacement in a native RVOT is a reasonable alternative to the surgical approach.
No takes yet. Share an insight, caveat, or question.
Auziņa et al. (2020) conducted a case report in Tetralogy of Fallot with progressive pulmonary regurgitation and right ventricle dilatation (n=1). Transcatheter pulmonary valve implantation using Edwards SAPIEN valve was evaluated on RVOT maximal peak systolic gradient and pulmonary regurgitation at 6 months. Transcatheter pulmonary valve implantation using the Edwards SAPIEN valve in the native RVOT was successful, resulting in a peak systolic gradient of 22 mmHg and no pulmonary regurgitation at 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: